Facebook
Twitter
LinkedIn
ForwardCOURSE DIRECTOR
David A. Wetter, M.D
DESCRIPTION
Dermatology Hospital Grand Rounds is a weekly conference to educate and train healthcare professionals on the pitfalls and challenges encountered in the management of complicated dermatological patients including topics on erythroderma, severe drug rashes, deep ulcers, blistering disorders, and cutaneous findings associated with systemic diseases in hospitalized patients.
TARGET AUDIENCE
The Dermatology Hospital Conference attendees will include Dermatology staff, PAs and residents. The target audience is the consulting staff and PAs. All attendees should have a basic knowledge of the specialty of dermatology and skin manifestations of systemic diseases, dermatopathology as well as pharmacology and therapeutics.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Identify how to effectively diagnose a variety of dermatologic conditions encountered in hospitalized patients.
- Review how to initiate an initial workup of a variety of dermatologic conditions encountered in hospitalized patients.
- Review how to treat and manage a variety of dermatologic conditions encountered in hospitalized patients.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
Afsaneh Alavi, M.D. - Consultant - Janssen Research Development, Johnson & Johnson, Innovaderm Research Inc., InflaRx, UCB, Inc., AbbVie Inc., Novartis Pharmaceuticals Corporation.
Mark D. P. Davis, M.D. - Consultant - Curis.; Board of Directors - Epien Medical, Inc.
All relevant financial relationships have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Hafsa M. Cantwell, M.D.
Mariam T. McEvoy, M.D.
David A. Wetter, M.D.
Dianna Wendt (Coordinator)
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
QUESTIONS?
Contact Dianna Wendt at ph. 4-3720.